INVIVO THERAPEUTICS HOLDINGS (NVIV)

US46186M6057 - Common Stock

0.3207  -0.17 (-34.28%)

After market: 0.231 -0.09 (-27.97%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
9.87M10.65M9.90M9.10M11.50M
Research and Development
4.08M5.23M4.38M3.94M5.60M
Selling, General, and Administrative Expenses
5.79M5.42M5.52M5.16M5.90M
Operating Income
-9.87M-10.65M-9.90M-9.10M-11.50M
Interest Income/Expense
530.00K150.00K0.0020.00K250.00K
Other Income/Expense
0.0010.00K0.000.00-590.00K
Income Before Taxes
-9.33M-10.49M-9.90M-9.07M-11.83M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-9.33M-10.49M-9.90M-9.07M-11.83M
EBITDA
N/A-10.59M-9.86M-9.05M-11.44M
 
Per Share Data
EPS Diluted Total Ops
-3.52-6.83-7.48-32.39-1.18K
Non GAAP EPS
N/AN/AN/AN/A-882.00
 
Statistics

All data in USD

Charts